tRNA threonylcarbamoyladenosine modification

pathway activity — cross-omics
GO:0002949Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the tRNA threonylcarbamoyladenosine modification pathway is significantly associated with the RNA expression of multiple genes, with the OV cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are YRDC, C2orf66, and PSMB2, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, tRNA threonylcarbamoyladenosine modification activity versus YRDC in OV (Pearson r = 0.50).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
OVYRDC →+0.406+0.138<.001<.00135
HNSCC2orf66 →+0.441+0.096.009.00234
BRCAPSMB2 →+0.620+0.151<.001<.00134
BRCANEBL →-0.811-0.119.006.00334
CCRCCPOF1B →-1.312-0.180.007<.00134
HNSCPPAT →+0.507+0.103.002.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0002949 vs YRDC — OV

Per-sample scatter of tRNA threonylcarbamoyladenosine modification activity vs YRDC in OV.

Explore this scatter interactively →

Exploration